MYD88 L265P mutation in Waldenstrom macroglobulinemiaStéphanie Poulain, Xavier Leleu|Blood|2013Cited by 229
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemiaCharles Herbaux, Matthew S. Davids, Stéphanie Poulain et al.|Blood|2021Cited by 37